title: Question 11: How should Allergic Bronchopulmonary Aspergillosis [ABPA] be managed in Cystic Fibrosis?
authors.affiliation: Department of Respiratory Medicine, The Children's Hospital at Westmead, Sydney, NSW 2145, Australia; Discipline of Child & Adolescent Health, Sydney Medical School, University of Sydney, Sydney, NSW, Australia. Electronic address: mon.ohn@health.nsw.gov.au.
authors.forename: Mon
authors.initials: M
authors.lastname: Ohn
authors.affiliation: Department of Respiratory Medicine, The Children's Hospital at Westmead, Sydney, NSW 2145, Australia; Discipline of Child & Adolescent Health, Sydney Medical School, University of Sydney, Sydney, NSW, Australia.
authors.forename: Paul
authors.initials: P
authors.lastname: Robinson
authors.affiliation: Department of Respiratory Medicine, The Children's Hospital at Westmead, Sydney, NSW 2145, Australia; Discipline of Child & Adolescent Health, Sydney Medical School, University of Sydney, Sydney, NSW, Australia.
authors.forename: Hiran
authors.initials: H
authors.lastname: Selvadurai
authors.affiliation: Department of Respiratory Medicine, The Children's Hospital at Westmead, Sydney, NSW 2145, Australia; Discipline of Child & Adolescent Health, Sydney Medical School, University of Sydney, Sydney, NSW, Australia.
authors.forename: Dominic A
authors.initials: DA
authors.lastname: Fitzgerald
mesh_terms: D001229:Aspergillosis, Allergic Bronchopulmonary / Q000209:etiology / Q000503:physiopathology / Q000628:therapy*; D003550:Cystic Fibrosis / Q000150:complications*; D006801:Humans; D010346:Patient Care Management / Q000379:methods*
keywords: Allergic bronchopulmonary aspergillosis [ABPA]; children; cystic fibrosis